U.S. market Closed. Opens in 16 hours 15 minutes

LTRN | Lantern Pharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue174.84K154.68K97.42K3.39K1.63KN/A
Gross Profit-174.84K-154.68K-97.42K-3.39K-1.63KN/A
Operating Expenses17.88M14.43M12.59M5.91M2.43M1.73M
Selling, General & Admin5.98M5.83M5.02M3.66M1.48M1.15M
Research & Development11.89M8.60M7.57M2.24M953.18K572.10K
Other Operating Expenses0-31.55K160.55KN/AN/AN/A
Operating Income-17.88M-14.43M-12.59M-5.91M-2.43M-1.73M
Other Expenses / Income1.92M172.81K228.48KN/A-5.00N/A
Before Tax Income-15.96M-14.26M-12.36M-5.91M-2.43M-1.73M
Income Tax Expenses-3.00-172.81K-67.93K-202.91K-5.002.54K
Net Income-15.96M-14.09M-12.30M-5.91M-2.43M-1.73M
Interest ExpensesN/A204.35KN/AN/AN/AN/A
Basic Shares Outstanding10.84M10.85M10.90M6.22M6.27M6.22M
Diluted Shares Outstanding10.84M10.85M10.90M6.22M6.27M6.22M
EBITDA-17.86M-14.42M-12.58M-5.90M-2.43M-1.73M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-15.96M-14.06M-12.36M-6.11M-2.43M-1.72M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙